Acurx Pharmaceuticals, Inc.
ACXP
$0.3543
$0.01885.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.41% | -18.29% | -30.45% | 24.27% | -17.97% |
| Total Receivables | -60.45% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.39% | 16.18% | 87.32% | -9.05% | -60.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -49.96% | -16.42% | -28.75% | 23.34% | -17.78% |
|
|
|||||
| Total Current Assets | -49.96% | -16.42% | -28.75% | 23.34% | -17.78% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -49.96% | -16.42% | -28.75% | 23.34% | -17.78% |
|
|
|||||
| Total Accounts Payable | 26.32% | 63.25% | -21.71% | -50.00% | -87.12% |
| Total Accrued Expenses | 6.57% | 2.74% | 4.53% | 50.86% | 49.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.59% | 2.96% | 4.42% | 49.96% | 47.57% |
|
|
|||||
| Total Current Liabilities | 6.59% | 2.96% | 4.42% | 49.96% | 47.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.59% | 2.96% | 4.42% | 49.96% | 47.57% |
|
|
|||||
| Common Stock & APIC | 17.36% | 29.14% | 27.22% | 35.73% | 25.96% |
| Retained Earnings | -26.50% | -34.17% | -37.19% | -38.64% | -37.73% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -86.82% | -32.29% | -44.86% | 12.94% | -36.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -86.82% | -32.29% | -44.86% | 12.94% | -36.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -86.82% | -32.29% | -44.86% | 12.94% | -36.20% |
|
|
|||||
